Advertisement

Covaxin: Bharat Biotech's corona vaccine will be 60% effective, says top official

Bharat Biotech's 'Covaxin', a potential vaccine against the coronavirus infection, will be at least 60 per cent effective and the Indian biotechnology company is aiming to launch the coronavirus vaccine candidate in Q2 of 2021, confirmed a top official of the company. In an exclusive interview with India Today TV, Sai D Prasad, president, Quality Operations at Bharat Biotech, said while the company is aiming for at least 60 per cent effectiveness of the coronavirus vaccine candidate 'Covaxin', it could also be more. Bharat Biotech and ICMR are working on 'Covaxin', one of the indigenous coronavirus vaccine candidates being developed in India. Watch this video to know more.

Read More

VIDEOS FROM OTHER SECTIONS

LATEST VIDEOS

advertisement

Iran has no choice but to fight back ferociously: Esmaeil Baghaei on war with US

In an exclusive interview with India Today TV, Esmaeil Baghaei, the spokesperson of the Ministry of Foreign Affairs of Iran, discussed Tehran's response to US President Donald Trump's threats. He detailed the history of Tehran's diplomatic engagement with Washington, highlighting the US withdrawal from the JCPOA and the assassination of IRGC Commander Qassem Soleimani. He explained Iran's recent proposal to end the war and reopen the Strait of Hormuz, which the US rejected. Baghaei stated, "Blockade itself is a declaration of an act of war," attributing the current international maritime and energy crises, including those affecting India, to actions by the US and Israel. He also questioned why the disarmament of Israel's nuclear weapons is not part of global demands, noting Iran's compliance with the NPT. Addressing the possibility of a ground invasion by the US, Baghaei affirmed Iran's military readiness, warning, "We have no other choice other than fighting back ferociously." He emphasised that Iran is defending its homeland and international law against aggression.